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CONSIDERABLE attention has been paid to the enzyme fi-glucuronidase in
connection with cancer. Physiological aspects of the action of this enzyme
have recently been reviewed by Levvy (1956). Various workers have found that
the ,-glucuronidase activity of malignant tumours in both humans and mice
is high in comparison with that of most normal organs, and usually much higher
than that of the surrounding healthy tissue. It has also been suggested (Odell
and Burt, 1950) that abnormally high figures for /-glucuronidase activity in
human vaginal fluid have diagnostic significance in uterine cervical cancer,
particularly prior to the menopause.
,8-Glucuronidase is practically ubiquitous in its distribution in the animal
body, but its activity in a given tissue bears no relation to the general metabolic
activity nor the oxygen uptake ofthe tissue. One possible function ofthe enzyme
is the hydrolysis of steroid glucuronides to release the active hormones, but this
provides no satisfactory explanation of the response in enhanced or diminished
activity of the enzyme in different organs to the administration of steroid
hormones, a phenomenon that has been extensively studied. It has been shown
(Linker, Meyer and Weissmann, 1955) that ,-glucuronidase and hydrolyses degra-
dation products from chondroitin and hyaluronic acid, and it may well be that a
r6ole in mucoid catabolism is at least as important a function of ,-glucuronidase
in the animal body. Such a r6le might be expected to assume major proportions
in tissue growth, repair or proliferation, as well as after steroid hormone admini-
stration, all these being conditions under which an enhancement of,-glucuronidase
activity has been frequently observed.
On this line of reasoning, it was considered that /-glucuronidase might be
in no way unique amongst glycosidases in its behaviour in vivo, and it has in fact
recently been found (Conchie, Findlay and Levvy, 1956, 1957) that ,-N-acetyl-
glucosaminidase and the newly-discovered a-mannosidase in mammalian tissues
do respond to steroid hormone administration. 8-N-Acetylglucosaminidase
has also been shown to participate in the catabolism of hyaluronic acid (Linker
et al., 1955), whilst it has been tentatively suggested that a-mannosidase may
have a similar role in the metabolism of mucoids containing mannose (Conchie
et al., 1956, 1957; Conchie and Mann, 1957). The present communication
deals with these enzymes in conditions of cancer, in comparison with
,8-glucuronidase.
MATERIALS AND METHODS
Materials
p-Nitrophenyl a-D-mannoside was prepared as described by Jermyn (1955)
and had m.p. 176° and [a] 19D + 145° (c, 0.2 in water).
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Phenyl N-acetyl /-D-glucosaminide was prepared as described by Conchie
and Levvy (1957).
Phenolphthalein f/-D-glucuronide was prepared biosynthetically (Talalay,
Fishman and Huggins, 1946).
The ascitic tumours S37, Ehrlich and 2146 were obtained from Professor
J. S. Young, Department of Pathology, University of Aberdeen, and were trans-
planted weekly into our laboratory strain of white mice (Tyler's Original: Mill
Hill colony).
Afrozen suspension ofTumour 2146 was obtained from Dr. J. Craigie, Imperial
Cancer Research Fund, and injected into our laboratory mice.
Mice with spontaneous mammary tumours, and those implanted with Crocker
sarcoma 180, were obtained from Professor A. Haddow, Chester Beatty Research
Institute.
Vaginal fluid samples were collected by Dr. J. G. Lawson, Department of
Midwifery, University of Aberdeen, who also supplied the specimens of genital
tumours.
Samples ofnormal human kidney tissue and of Grawitz tumour were supplied
by Dr. A. J. Carr, Department of Pathology, University of Aberdeen.
Method8
Enzyme preparations.-All tissues to be assayed were first homogenised in
water with a glass homogeniser. The suspensions were diluted so that under
the conditions of assay they liberated from the substrate suitable amounts of
aglycone (80-100 ptg. p-nitrophenol, 40-50 ,g. phenol and 30-40 ,ug. phenol-
phthalein). In the case of/-N-acetylglucosaminidase assays, the homogenates,
after incubation for 1 hour at 37° with 0.05 M citric acid buffer pH 4.3, followed
by the addition of 0.15 M sodium chloride (Pugh, Leaback and Walker, 1957a),
were centrifuged and the supernatant fractionated with saturated ammonium
sulphate, the fraction precipitated between 20 and 80 per cent saturation being
used for assay. This avoided the high enzyme blanks usually obtained with
crude homogenates when estimating phenol.
Ascitic fluids were either diluted with water and homogenised or were mixed
with Triton X-100 (Rohm & Haas Company-0.6 per cent final concentration)
to rupture the cells before assay.
Vaginal fluid samples were also diluted and homogenised. In view of the
small amounts of fluid available, incubations were carried out for 2 hours instead
of 1 hour in the case of a-mannosidase assays.
Assays.-Estimations ofa-mannosidase activity were carried out in phosphate-
citrate buffer pH 4-6 with p-nitrophenyl o-mannoside as substrate. To 3 ml.
of buffer were added 0.5 ml. of 0.016 M substrate and 0.5 ml. enzyme solution
and the mixture incubated for 1 hour at 37°. The reaction was stopped by the
addition of 2 ml. trichloroacetic acid (5 per cent w/v), and 4 ml. of the reaction
mixture neutralised with NaOH and developed with glycine-Na2CO3 buffer as
described by Conchie (1954) for 8-glucosidase assays. The free p-nitrophenol
was measured on the Spekker photoelectric absorptiometer using an Ilford 601
violet filter.
,-N-Acetylglucosaminidase activity was measured by the method of Kerr,
Graham and Lewvvy (1948), the liberated phenol being measured using an Ilford
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No. 608 red filter in the absorptiometer. The conditions of assay were those
described by Pugh, Leaback and Walker (1957b).
fJ-Glucuronidase activity was measured by the method described by Levvy
(1952) for mouse-liver fi-glucuronidase.
RESULTS
Table I shows mean figures for the x-mannosidase, f-glucuronidase and
fi-N-acetylglucosaminidase activities of various mouse tumours, in comparison
with figures for uninvolved liver in the same groups of mice. Liver is among
the richer tissues in all three enzyme activities. With the exception of the C3H
mice, the animals were drawnfromvarious mixedbreeding colonies. Spontaneous
mammary tumours and Crocker sarcoma 180 showed activity levels for all three
enzymes of the same order as those seen in liver. It should be noted that the
C3H strain is one with a genetically-determined low fl-glucuronidase activity
in all tissues (Law, Morrow and Greenspan, 1952). It is also, in our experience,
a very unthrifty and infertile strain. Cohen and Bittner (1951) showed that the
hereditary factor extended to f-glucuronidase in cancer tissue. It is evident
from our results that the a-mannosidase and,-N-acetylglucosaminidase activities
are not genetically linked to f-glucuronidase activity.
TABLE I.-Enzyme Activities in Mouse Tumours
For conditionsofassayseetext. Resultsareexpressedin/ug.p-nitrophenol,phenol-
phthalein or phenol liberated per g. of tissue (wet weight) in 1 hour.
Uninvolved liver shown for comparison.
Values are given as mean ± standard errorfollowed (inparentheses) bythe
number of animals in the group.
Enzyme activities
C- --
Tumour
Spontaneous mammary tumour:
Mixed strain: Tumour
Liver
C3H strain: Tumour
Liver
Crocker sarcoma 180 (subcutaneous injec-
tion):
Tumour . .
Liver . .
Ascitic tumours (intraperitoneal injec-
tion):*
S37 tumour .
Ehrlich tumour
2146 tumour .
Liver
Subcutaneous injection of ascitic fluid:
2146 tumour (frozen)t
2146 tumour (fresh)t .
2146 tumour (fresh: 2nd subcutaneous
transplant)
Ehrlich tumour ..
Liver ..
oc-Mannosidase
3,750+440 (9)
1,352
1,320±4 (2)
1,311
1,150±85 (9)
2,587
112±4 (3)
114i±11 (3)
116± 14 (3)
1,572
600+60 (5)
480±50 (13)
490±37 (9)
720+70 (2)
1,604
3-Glucuronidase
2,280+ 130 (9)
2,631
650±48 (2)
319
2,100±680 (5)
2,498
140±16 (2)
207±+40 (3)
146±3 (2)
2,300
2,060±42 (5)
1,880±200 (13)
1,540i 110 (9)
1,940±390 (2)
2,927
P-N-Acetyl-
glucosaminidase
7,830i 1,350 (5)
7,312
3,937 ± 120 (2)
6,170
4,120±500 (7)
9,030
1,190±90 (2)
1,400± 130 (2)
1,240i±200 (2)
10,430
5,890±300 (3)
7,570±700 (13)
7,470±710 (4)
7,430+560 (2)
7,781
* Results expressed per ml. ascitic fluid.
t These tumours were of diverse origin, the second specimen have been kept in the ascitic formn
for several generations.
489J. CONCHIE AND G. A. LEVVY
Ascitic tumours would appear to be a major exception to the generalisation
that tumours have a relatively high /6-glucuronidase activity, since they had
only about one-sixteenth the value for liver. This difference between ascitic
and other tumours extended to c-mannosidase and fl-N-acetylglucosaminidase
activity.
Thus far it can be seen that both the a-mannosidase and /8-N-acetyl-
glucosaminidase activities of tumours paralleled their fi-glucuronidase activity.
After subcutaneous injection of tumours that had been through the ascitic phase,
however, c-mannosidase displayed a low figure in the tumour in comparison
with that for liver, whereas fi-glucuronidase and fl-N-acetylglucosaminidase
displayed similar values to those observed with spontaneous mammary tumours
and Crocker sarcoma 180. As regards the latter two enzymes at least, the site
ofinjection would appear to be the sole determining factor for the enzyme activity
of the resultant tumour.
A fewfigures for human surgical specimens are shown in Table II. From these
few results it cannot be said that the/-glucuronidase activity of cancerous tissues
TABLE II.-Enzyme Activities in Some Human Tumours
and in Uninvolved Tissue
For conditions ofassay seetext. Results areexpressed inpg. p-nitrophenol,
phenolphthalein or phenol liberated by 1 g. tissue (wet weight) in 1 hour.
Enzyme activities
P-N-Acetyl-
x-Manno- P-Glucu- glucos-
Subject Age Specimen sidase ronidase aminidase
Mrs. J. C- 65 Cancerous vulva 715 446 7,943
Mrs. C. W- . 41 . Malignant anterior lip ofcervix 721 479 7,021
Non-malignant posterior lip of . 218 479 6,211
cervix
Mrs. H. O0- . 47 . Cancerous uterine body . 818 818 19,900
Mrs. M. McK- . 64 . Grawitz tumour . 351 635 4,301
Normal kidney tissue . 1,105 1,793 22,040
was any higher than that ofthe corresponding healthy tissue, nor did this appear
to be true for o-mannosidase and /?-N-acetylglucosaminidase. It can, however,
be seen that o-mannosidase and f/-N-acetylglucosaminidase activities in human
tissues are at least comparable with that of,8-glucuronidase.
Table III gives individual figures for the activities of the enzymes in vaginal
fluid from human subjects, with and without genital cancer. Figures for /8-
glucuronidase were obtained by Dr. J. G. Lawson. It has been stated that a
vaginal fluid f/-glucuronidase activity of 400 units per g. fluid distinguishes
normal premenopausal women from those with cancer of the uterine cervix,
80 to 90 per cent of the women falling into the correct category (Kasdon,
Homburger, Yorshis and Fishman, 1953): healthy postmenopausal women
frequently display a high value, the enzyme in vaginal fluid being apparently
under ovarian control. The data in Table III suggest that a similar test might
be founded on the a-mannosidase activity of vaginal fluid, with a dividing line
at about 200 units per g. fluid, and with the added advantage that in healthy
women zero values are frequently observed for this enzyme: the only false high
value was in a post-menopausal woman. It is interesting to recall in this
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TABLE III.-Enzyme Activities in Vaginal Fluids
Forconditions ofassayseetext. Results areexpessedas/g. ofp-nitrophenol,
phenolphthalein or phenol liberated per g. offluid in 1 hour.
(a) Vaginal fluids from cancer patiei
Subject
Mrs. T. B-
Mrs. C. C-
Age
. 48
. 76
Meno-
pause
. Pre
. Post
Mrs. A. M- . 61 . Post
Mrs. C. W- . 41 . Pre
Mrs. M. T- . 70 . Post
Mrs. H. 0- . 47 . Pre
Mrs. J. C- . 65 . Post
Condition
. Carcinoma of cervix (untreated)
Advanced carcinoma ofcervix and
vagina (2 days afterradium treat-
ment)
Four days after radium treatment
. Carcinoma of cervix (2 days after .
radium treatment)
Carcinoma of cervix (untreated)
Three weeks after first radium.
treatment
Carcinoma ofcervix (untreated)
Cancer ofuterine body with spread
down vagina (untreated)
Advanced carcinoma ofvulva (un-
treated)
nts
Enzyme activities
- -
,-N-
Acetyl-
m-Mannos- 3-Glucu- glucos-
idase ronidase aminidase
246 566 -
1350 1266 -
540
155
Nil
652
335 -
186 -
405
768 2015
923 747 2418
413 337 1399
Nil 230
(b) Vaginal fluids from non-cancer subjects
Enzyme activities
le A -
Subject
Mrs. J. L-
Mrs. E. H-
Mrs. I. T-
Mrs. I. D-
Mrs. I. B-
Mrs. I. S-
Mrs. C. R-
Miss I. R-
Mrs. E. D-
Age
32
37
46
51
41
70
44
24
26
Menopause
Pre
Pre
Pre
Post
Pre
Post
Pre
Pre
Pre
P-N-Acetyl-
m-Mannosidase ,-Glucuronidase glucosaminidase
Nil 100 -
171 - 2568
Nil -108
Nil - 491
174 - 814
1064 - 3483
321t - 5142t
- - 347
--~- ~ 811
t Non-malignant fibroid growth in uterus.
connection that ovariectomy reduces mouse uterine a-mannosidase activity to
vanishingly small proportions (Conchie, Findlay and Lewvvy, 1957), whereas the
/I-glucuronidase activity is only reduced to about half by this measure (Kerr,
Campbell and Levvy, 1949; Fishman and Fishman, 1944; Fishman and
Farmelant, 1953). fl-N-Acetylglucosaminidase activity did not appear to
distinguish between normal women and cancer cases, but the results for this
enzyme are too few to form any definite opinion.
DISCUSSION
f,-Glucuronidase can no longer be regarded as unique amongst mammalian
glycosidases, since c-mannosidase and fl-N-acetylglucosaminidase show an
equally wide distribution in the body, respond to steroid hormone administration
and, as we have just seen, show similar activities in cancer tissue as compared
with appropriate healthy tissue values. It would also appear that the correlation
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between high,/-glucuronidase activity and malignant growths is not as invariable
as has been generally believed. The relatively very low /,8-glucuronidase activity
of ascitic tumours is particularly perplexing, unless the high ,8-glucuronidase
activity of most other tumours is associated with the invasion of solid body
tissues. With regard to /8-glucuronidase assay as an aid in the diagnosis of
uterine cervical cancer, it would appear that a-mannosidase assay might be
equally well employed, perhaps with advantage.
The secretion of ,-N-acetylglucosaminidase in normal vaginal fluid is of
particular interest in view of the very high activity of this enzyme in the semen
of all species, including man (Conchie and Mann, 1957).
There is no evidence whatsoever for the conjugation of steroid hormones or
their metabolites with mannose or N-acetylglucosamine, and there can thus be
no attempt to explain an enhanced activity of either a-mannosidase or /8-N-
acetylglucosaminidase in terms of an adaptation by the organism to meet a need
for increased metabolism of these hormones. It is much more probable that a
high activity of these enzymes, whether caused by steroid hormones or other
means, reflects an increase in mucoid catabolism, and this same explanation
may very well extend to /?-glucuronidase. The fact that steroid hormones, as
well as altering f/-glucuronidase activity in vivo, form conjugates that are
hydrolysed by this enzyme can thus be regarded as purely coincidental.
Maintaining an overall balance in the body with the forces of synthesis would
appear to provide a vital function for hydrolytic enzymes such as these, quite
apart from any specialised action, such as the release of steroid hormones from
conjugates by /?-glucuronidase.
SUMMARY
Mouse and human malignant tumours as well as vaginal fluid from cases of
uterine cervical cancer, have been examined for their a-mannosidase and 8-N-
acetylglucosaminidase activity. In most respects these two enzymes resembled
/?-glucuronidase, an enzyme that has been extensively studied in connection
with cancer. Ascitic tumours displayed astonishingly low values for /-
glucuronidase activity as well as for the other two enzymes examined. The
preliminary results suggested that a-mannosidase assay in vaginal fluid might
be as useful as a diagnostic aid in uterine cervical cancer as the measurement
of/-glucuronidase activity.
We are indebted to Mr. A. J. Hay for competent technical assistance.
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